Alveolar Ridge and Soft Tissue Augmentation Using Graft From the Maxillary Tuberosity

NCT ID: NCT05670067

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

24 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-10-30

Study Completion Date

2025-01-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In the study immediate implant is placed in the anterior region with autogenous bone grafting from the maxillary tuberosity in one group and in the other group immediate implant is placed with xenograft .IN both groups soft tissue grafting is done using connective tissue assessment of buccal bone thickness and soft tissue will be done 6 months post operative

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

immediate implant will be placed in the anterior region with autogenous graft from the maxillary tuberosity and in the other group immediate implant will be laced with xenograft soft tissue grafting using sub-epithelial connective tissue will in both groups assessment of buccal bone thickness is the primary outcome of the study, while volumetric assessment of the soft tissue and patient satisfaction are the secondary and tertiary outcome the assessment of all outcome will be 6 months post operative the extraction socket in which the implant will be placed are class I\&II

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Immediate Implant Placement

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

two group in which the same procedure is done ( immediate implant placement) using different bone grafts
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
the outcome assessor will not know the grouping of the study he will only know that immediate implant was placed in both groups

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

immediate implant with bone graft (autogenous)

with immediate implant placement autogenous grafting using maxillary tuberosity will be done

Group Type ACTIVE_COMPARATOR

maxillary tuberosity bone graft (autogenous graft)

Intervention Type PROCEDURE

the usage of maxillary tuberosity as source of autogenous graft supplying the needed cells for bone regeneration

immediate implant with bonegraft (xenograft)

with immediate implant placement grafting with xenograft will be done

Group Type ACTIVE_COMPARATOR

Bone graft (xenograft)

Intervention Type PROCEDURE

xenograft is bone graft material that is obtained from porcine, bovine or equine source

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

maxillary tuberosity bone graft (autogenous graft)

the usage of maxillary tuberosity as source of autogenous graft supplying the needed cells for bone regeneration

Intervention Type PROCEDURE

Bone graft (xenograft)

xenograft is bone graft material that is obtained from porcine, bovine or equine source

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Systemically healthy patients (American Society of Anesthesiologists I; ASA I).
* Age range (20-40) years.
* Good compliance with the plaque control instructions following initial therapy.
* Patients diagnosed with bone defect in the maxillary anterior esthetic zone (class 1 \& 2)
* Availability for follow up and maintenance program.

Exclusion Criteria

* Peri apically infected teeth
* Presence of smoking habit.
* Presence of occlusal interferences.
* Pregnant females.
* Vulnerable group of patients (handicapped, mentally retarded and prisoners) (according to the recommendation of esthetical committee of Faculty of Dentistry Ain Shams University).
Minimum Eligible Age

20 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ain Shams University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ahmed Hesham Mohamed

assistant lecturer

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hala Abu el ela, Prof

Role: STUDY_DIRECTOR

Faculty of dentistry ain shams university

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Dentistry Ain Shams University

Cairo, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

no 948

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autogenous Tooth Graft for Ridge Augmentation
NCT06416605 ACTIVE_NOT_RECRUITING NA